Acutus is rolling out the AcQCross Qx left-heart access system for use with Boston Scientific’s TruSeal and FXD delivery systems for its Watchman left-atrial appendage closure devices.
In February 2022, the US Food and Drug Administration cleared the latest model of AcQCross Qx as an integrated...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?